According To The Coherent Market Insights The global deep brain stimulation devices market for Parkinson’s disease is estimated to be valued at US$ 3,567.6 million in 2021 and is expected to exhibit a CAGR of 8.3 % over the forecast period (2021-2028).Deep brain stimulation (DBS) technology, frequently defined as brain pacemaker, aids in relieving symptoms of Parkinson’s disease (PD) (PD). Deep Brain Stimulation Devices are implanted at one of the three U.S. Food and Drug Administration (FDA) authorised brain locations to block the electrical signals from these sites to the brain.
read more..